19-57537542-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001199295.2(ZNF549):c.538A>T(p.Asn180Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199295.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF549 | NM_001199295.2 | c.538A>T | p.Asn180Tyr | missense_variant | 4/4 | ENST00000376233.8 | NP_001186224.2 | |
ZNF549 | NM_153263.3 | c.499A>T | p.Asn167Tyr | missense_variant | 3/3 | NP_694995.3 | ||
ZNF549 | XM_047438563.1 | c.625A>T | p.Asn209Tyr | missense_variant | 3/3 | XP_047294519.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251448Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135902
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727248
GnomAD4 genome AF: 0.000131 AC: 20AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.538A>T (p.N180Y) alteration is located in exon 4 (coding exon 4) of the ZNF549 gene. This alteration results from a A to T substitution at nucleotide position 538, causing the asparagine (N) at amino acid position 180 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at